Mirabella Financial Services LLP Aldeyra Therapeutics, Inc. Transaction History

Mirabella Financial Services LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$5.77 - $9.93 $67,232 - $115,704	11,652 Added 55.86%	32,510 $322,000
Q4 2022 Feb 13, 2023	BUY	$5.08 - $7.09 $105,958 - $147,883	20,858 New	20,858 $145,000
Q1 2021 May 17, 2021	SELL	$6.53 - $14.42 $134,615 - $297,268	-20,615 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.31 - $8.13 $18,381 - $23,682	-2,913 Reduced 12.38%	20,615 $141,000
Q3 2020 Nov 13, 2020	BUY	$4.0 - $7.53 $94,112 - $177,165	23,528 New	23,528 $174,000

116

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $318M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.